Gene · 8505
Papers1,648
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,648
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations. | Diagn Pathol | 2024 | 38184614 | PubTator, text mining | PubMed |
| Covalent PARylation of DNA base excision repair proteins regulates DNA demethylation. | Nat Commun | 2024 | 38167803 | PubTator, text mining | PubMed |
| DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids. | Nucleic Acids Res | 2024 | 38000390 | PubTator, text mining | PubMed |
| Novel PNKP mutations associated with reduced DNA single-strand break repair and severe microcephaly, seizures, and developmental delay. | Mol Genet Genomic Med | 2024 | 37916443 | PubTator, text mining | PubMed |
| Mechanism of PARP inhibitor resistance and potential overcoming strategies. | Genes Dis | 2024 | 37588193 | PubTator, text mining | PubMed |
| PARG Promotes Esophagus Cancer Cell Metastasis by Activation of the Wnt/β-Catenin Pathway. | Biochem Genet | 2024 | 37429965 | PubTator, text mining | PubMed |
| Mechanism-based Suppression of Cancer by Targeting DNA-Replicating Enzymes. | Curr Protein Pept Sci | 2024 | 37183462 | PubTator, text mining | PubMed |
| Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. | Viruses | 2023 | 38140532 | PubTator, text mining | PubMed |
| Disrupting Poly(ADP-ribosyl)ating Pathway Creates Premalignant Conditions in Mammalian Liver. | Int J Mol Sci | 2023 | 38139034 | PubTator, text mining | PubMed |
| Polyadenosine diphosphate-ribose polymerase inhibitors: advances, implications, and challenges in tumor radiotherapy sensitization. | Front Oncol | 2023 | 38111536 | PubTator, text mining | PubMed |
| Life-Cycle-Dependent Toxicities of Mono- and Bifunctional Alkylating Agents in the 3R-Compliant Model Organism C. elegans. | Cells | 2023 | 38067156 | PubTator, text mining | PubMed |
| ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars. | Proc Natl Acad Sci U S A | 2023 | 38060563 | PubTator, text mining | PubMed |
| Positive selection analyses identify a single WWE domain residue that shapes ZAP into a super restriction factor. | bioRxiv | 2023 | 38045310 | PubTator, text mining | PubMed |
| Single-cell profiling reveals tumour cell heterogeneity accompanying a pre-malignant and immunosuppressive microenvironment in gastric adenocarcinoma. | Clin Transl Med | 2023 | 38037525 | PubTator, text mining | PubMed |
| Poly(ADP-ribosyl)ating enzymes coordinate changes in the expression of metabolic genes with developmental progression. | Sci Rep | 2023 | 37985852 | PubTator, text mining | PubMed |
| The TDRD3-USP9X complex and MIB1 regulate TOP3B homeostasis and prevent deleterious TOP3B cleavage complexes. | Nat Commun | 2023 | 37980342 | PubTator, text mining | PubMed |
| Sulfoquinovosyl acylpropanediol (SQAP): Inhibition of poly(ADP-ribose) metabolism and enhanced cytotoxicity in homologous recombination repair-deficient Chinese hamster-derived cells. | Mutat Res Genet Toxicol Environ Mutagen | 2023 | 37973295 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| Advancements and Obstacles of PARP Inhibitors in Gastric Cancer. | Cancers (Basel) | 2023 | 37958290 | PubTator, text mining | PubMed |
| Multiple E3 ligases control tankyrase stability and function. | Nat Commun | 2023 | 37938264 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8505/papers?page=6